Suchergebnisse - "Zhu, Xuyou"

PubPharm (47)

1

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling

enthalten in: Cell death & disease | 2024

von Yang, T. | Chi, Y. | Wang, X. | +8

2

Clinicopathological features and genomic analysis of bronchiolar adenoma

enthalten in: Histology and histopathology | 2023

von Bo, J. | Chen, X. | Zhang, T. | +9

3

Correlation of 3'-phosphoadenosine-5'-phosphosulfate synthase 1 (PAPSS1) expression with clinical parameters and prognosis in esophageal squamous cell carcinoma

enthalten in: Histology and histopathology | 2023

von Zhu, X. | Zhu, P. | Chen, X. | +8

4

Screening of immune-related lncRNAs in lung adenocarcinoma and establishing a survival prognostic risk prediction model

enthalten in: Combinatorial chemistry & high throughput screening | 2023

von Jiang, W. | Zhu, X. | Bo, J. | +1

5

Almond polypeptide sunscreen moisturizing skin care product and preparation method thereof

enthalten in: Europäisches Patentamt | 2023

von WUYUN TANA | ZHU XUCHUN | LIU HUIMIN | +5

6

Evaluation of new robust silk fibroin hydrogels for posterior scleral reinforcement in rabbits

enthalten in: Frontiers in bioengineering and biotechnology | 2023

von Xu, Y. | Chen, Q. | Shao, Z. | +6

7

Combination of transbronchial cryobiopsy based clinic-radiologic-pathologic strategy and metagenomic next-generation sequencing for differential diagnosis of rapidly progressive diffuse parenchymal lung diseases

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Sun, H. | Chen, R. | Li, T. | +6

8

TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients

enthalten in: Journal of cancer research and clinical oncology | 2022

von Fang, X. | Wu, G. | Hua, J. | +12

9

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer

enthalten in: The Prostate | 2022

von Yang, T. | Liu, Y. | Chen, S. | +14

10

Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment

enthalten in: Cell reports. Medicine | 2022

von Mei, Z. | Yang, T. | Liu, Y. | +16

1
2
3
4
5
Nächster »
[5]